您的位置: 首页 > 农业专利 > 详情页

多發性骨髓瘤的羅尼哌他組合治療
专利权人:
Leadiant Biosciences SA in liquidazione;THE UAB RESEARCH FOUNDATION
发明人:
SANDERSON, Ralph D,PRAKASH C. RAMANI, Vishnu,NOSEDA, Alessandro,BARBIERI, Paola,NOSEDA, Alessandro,亞歷山大‧諾塞達,BARBIERI, Paola,保拉‧巴爾維里
申请号:
HK18104587.1
公开号:
HK1245107A
申请日:
2018.04.09
申请国别(地区):
HK
年份:
2018
代理人:
摘要:
The present invention relates to roneparstat for use in a combined therapy for the treatment of multiple myeloma. In particular it has unexpectedly been found that the combined use of roneparstat with a proteasome inhibitor, in particular selected between bortezomib and carfilzomib improve efficacy in decreasing the overall tumor burden, especially showing synergism, with respect to the administration of each active ingredient alone.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充